Epigenomic disruption: the effects of early developmental exposures. Birth defects research Part A, Clinical and molecular teratology, pp.938-944, 2010. ,
Epigenetic transgenerational actions of endocrine disruptors, Reproductive Toxicology, vol.31, issue.3, pp.337-343, 2011. ,
DOI : 10.1016/j.reprotox.2010.10.012
The role of developmental plasticity and epigenetics in human health. Birth defects research Part C, Embryo today: reviews, pp.12-18, 2011. ,
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses, Endocrine Reviews, vol.33, issue.3, pp.378-455, 2012. ,
DOI : 10.1210/er.2011-1050
Endocrine disrupters as obesogens, Molecular and Cellular Endocrinology, vol.304, issue.1-2, pp.19-29, 2009. ,
DOI : 10.1016/j.mce.2009.02.018
Developmental neurotoxicity of industrial chemicals, The Lancet, vol.368, issue.9553, pp.2167-2178, 2006. ,
DOI : 10.1016/S0140-6736(06)69665-7
The Faroes Statement: Human Health Effects of Developmental Exposure to Chemicals in Our Environment, Basic & Clinical Pharmacology & Toxicology, vol.0, issue.0, pp.73-75, 2008. ,
DOI : 10.1111/j.1742-7843.2007.00114.x
URL : https://hal.archives-ouvertes.fr/inserm-00528822
Endocrine disrupting chemicals and disease susceptibility, The Journal of Steroid Biochemistry and Molecular Biology, vol.127, issue.3-5, pp.204-215, 2011. ,
DOI : 10.1016/j.jsbmb.2011.08.007
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3220783
Developmental origins of non-communicable disease: Implications for research and public health, Environmental Health, vol.127, issue.3, p.42, 2012. ,
DOI : 10.1016/j.jsbmb.2011.08.007
URL : https://hal.archives-ouvertes.fr/inserm-00712586